Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001600132-16-000066)

Filing Details

Accession Number:: 0001600132-16-000066
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-18 13:46:32
Reporting Period:: 2016-05-17

Filing Date:: 2016-05-18
Accepted Time:: 2016-05-18 13:46:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1600132	Bellerophon Therapeutics Inc.	BLPH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1500241	M Jonathan Peacock	C/O Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ 07059	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-05-17	5,000	$1.37	222,702	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price reported represents the weighted average sales price of shares purchased in multiple transactions at prices ranging from $1.33 to $1.37 per share. The reporting person hereby undertakes upon the request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.